A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus

Conditions:   Obesity;   Diabetes Mellitus, Type 2 Interventions:   Drug: JNJ-64565111 Dose Level 1;   Drug: JNJ-64565111 Dose Level 2;   Drug: JNJ-64565111 Dose Level 3;   Drug: Placebo Sponsor:   Janssen Research & Development, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials